Open access · CC-BY
via OpenAlex
Host-Microbe-Drug-Nutrient Screen Identifies Bacterial Effectors of Metformin Therapy
Rosina E. Pryor, Povilas Norvaišas, Γεώργιος Μαρίνος, Lena Best, Louise Bruun Thingholm, Leonor M. Quintaneiro, Wouter De Haes, Daniela Esser, Silvio Waschina, Celia Lujan, Reuben L. Smith, Timothy A. Scott, Daniel Martínez‐Martínez, Orla R. M. Woodward, Kevin Bryson
Cell · 2019 · ▲ 274 citations
Abstract
Metformin is the first-line therapy for treating type 2 diabetes and a promising anti-aging drug. We set out to address the fundamental question of how gut microbes and nutrition, key regulators of host physiology, affect the effects of metformin. Combining two tractable genetic models, the bacterium E. coli and the nematode C. elegans, we developed a high-throughput four-way screen to define the underlying host-microbe-drug-nutrient interactions. We show that microbes integrate cues from metformin and the diet through the phosphotransferase signaling pathway that converges on the transcriptional regulator Crp. A detailed experimental characterization of metformin effects downstream of Crp in combination with metabolic modeling of the microbiota in metformin-treated type 2 diabetic patients predicts the production of microbial agmatine, a regulator of metformin effects on host lipid metabolism and lifespan. Our high-throughput screening platform paves the way for identifying exploitable drug-nutrient-microbiome interactions to improve host health and longevity through targeted microbiome therapies. VIDEO ABSTRACT.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.cell.2019.08.003
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Pryor, R.E., Norvaišas, P., Μαρίνος, �., Best, L., Thingholm, L.B., Quintaneiro, L.M., Haes, W.D., Esser, D., Waschina, S., Lujan, C., Smith, R.L., Scott, T.A., Martínez‐Martínez, D., Woodward, O.R.M., Bryson, K., Laudes, M., Lieb, W., Houtkooper, R.H., Franke, A., & Temmerman, L. (2019). Host-Microbe-Drug-Nutrient Screen Identifies Bacterial Effectors of Metformin Therapy. <em>Cell</em>. https://doi.org/10.1016/j.cell.2019.08.003
Vancouver
Pryor RE, Norvaišas P, Μαρίνος �, Best L, Thingholm LB, Quintaneiro LM, et al. Host-Microbe-Drug-Nutrient Screen Identifies Bacterial Effectors of Metformin Therapy. Cell. 2019. doi:10.1016/j.cell.2019.08.003.
BibTeX
@article{rosina2019HostMi,
title = {Host-Microbe-Drug-Nutrient Screen Identifies Bacterial Effectors of Metformin Therapy},
author = {Rosina E. Pryor and Povilas Norvaišas and Γεώργιος Μαρίνος and Lena Best and Louise Bruun Thingholm and Leonor M. Quintaneiro and Wouter De Haes and Daniela Esser and Silvio Waschina and Celia Lujan and Reuben L. Smith and Timothy A. Scott and Daniel Martínez‐Martínez and Orla R. M. Woodward and Kevin Bryson and Matthias Laudes and Wolfgang Lieb and Riekelt H. Houtkooper and André Franke and Liesbet Temmerman and Ivana Bjedov and Helena M. Cochemé and Christoph Kaleta and Filipe Cabreiro},
journal = {Cell},
year = {2019},
doi = {10.1016/j.cell.2019.08.003},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Physiology 2020
Preprint · OA
Exercise-Pharmacology Interactions: Metformin, Statins, and Healthspan
bioRxiv (Cold Spring Harbor Laboratory) 2025
Preprint · OA
Broad Effects of Activation of Alcohol Dehydrogenase 1 on Healthspan Extension
2025
Preprint
Broad Effects of Activation of Alcohol Dehydrogenase 1 on Healthspan Extension
European Journal of Endocrinology 2014
Citation only
MECHANISMS IN ENDOCRINOLOGY: Gut microbiota in patients with type 2 diabetes mellitus
Scientific Reports 2017
Open access · CC-BY
The Transcription Factor DAF-16 is Essential for Increased Longevity in C. elegans Exposed to Bifidobacterium longum BB68
Aging Cell 2025
Open access · CC-BY